23andMe seeks Chapter 11 bankruptcy, secures $35M DIP financing. CEO steps down, CFO appointed Interim CEO. Anticipates rejecting real property leases and resolving legal claims stemming from a 2023 cyber breach. 45-day bidding process for qualified buyers underway.
PermRock Royalty Trust completes the sale of underlying oil and gas properties to T2S Permian Acquisition II, with Boaz Energy assisting in the transition. Boaz Energy also sold 4,884,861 Trust units to Ustx LLC, a subsidiary of T2S Permian. Argent Trust Company will continue normal administration.
Sterling Bancorp (NASDAQ: SBT) completes the $261 million sale of Sterling Bank and Trust to EverBank Financial, effective April 1, 2025. All branches except Michigan will transition to EverBank, and Sterling will file for dissolution and delist from Nasdaq. Four directors have resigned.
R1 and Palantir Technologies launch R37, an AI lab transforming healthcare financial performance. Leveraging R1's extensive data and Palantir's AI, the lab aims to develop intelligent automation solutions for coding, billing, and denials management, with full deployment planned for H2 2025.
Acquisition of Innovative Monoclonal Antibody
Scinai Immunotherapeutics (Nasdaq: SCNI) inked a binding option agreement to purchase Italian biotech company Pincell srl, taking an interest in PC111, a monoclonal antibody in development for severe dermatological conditions like Pemphigus, Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN)....
The UK stock market in 2025 combines growth in technology, healthcare, and renewable energy sectors, with risks from high interest rates and geopolitical tensions. Caution is advised due to ongoing uncertainties.
